The maker of a popular medicine for schizophrenia has notified doctors that it minimized potentially fatal safety risks and made misleading claims about the drug in promotional materials.

Janssen Pharmaceutic Products sent a two-page letter to the health care community this past week to clarify the risks of Risperdal, Carol Goodrich, a spokeswoman for the Johnson & Johnson subsidiary, said Saturday.

 


Comments


View Comments / Leave a Comment

This post currently has 0 comments.
You can read the comments or leave your own thoughts.


    Last reviewed: By John M. Grohol, Psy.D. on 27 Jul 2004
    Published on PsychCentral.com. All rights reserved.

APA Reference
Grohol, J. (2004). Drug Maker Acknowledges Misleading Claims. Psych Central. Retrieved on November 26, 2014, from http://psychcentral.com/blog/archives/2004/07/27/drug-maker-acknowledges-misleading-claims/

 

Recent Comments
  • David Hawkins: Hi Samantha, Great share.I agree with your opinion.For the most time the reason of going to a...
  • I'm Trying: My advice to you Matt is to NOT do it. Scroll up a few posts snd you will see that I too struggle with...
  • Rishi: Really nice article Michael. Thanks for sharing
  • Baby cakes: This article sounds like it came out of an experience with strange ets orbiting the earth. Is this site...
  • Sally: Well here I am alone at Thanksgiving with 2 cats. My husband passed away in 2008 and the holidays bring back...
Subscribe to Our Weekly Newsletter


Find a Therapist
Enter ZIP or postal code



Users Online: 11747
Join Us Now!